We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

血清钙水平低增加SCA风险

By LabMedica International staff writers
Posted on 06 Dec 2017
Print article
图片:研究显示血液中钙水平较低的人比钙水平高者更可能发生SCA(图片蒙SPL惠赐)。
图片:研究显示血液中钙水平较低的人比钙水平高者更可能发生SCA(图片蒙SPL惠赐)。
90%以上患者的突发性心脏骤停(SCA)致命,死于SCA的男性有超过一半、女性近70%此前没有临床心脏病史。它是美国的主要死因之一,比任何一种癌症致死的人都多。

根据现行指导意见,许多SCA患者不算高风险者。这些冷峻的事实迫使人们寻找相对不贵的简单方法来发现SCA风险较高的人。血液中钙水平很容易监测,钙水平较低的人比钙水平高者更可能发生SCA。

一组科学家与美国加利福尼亚州洛杉矶市西达斯-西奈心脏研究所的科学家合作,在对267名SCA患者和445名对照者的日常护理过程中测量了血清中的钙水平。在所有SCA病例心脏骤停的90天前测量血清钙水平。根据每名患者的血清白蛋白水平校正总血清钙,估计一个与生理更相关的钙水平。如果病人的年龄是18岁或以上,且已知肌酐清除率(CrCl)和血清电解质水平,就纳入研究;通过分析肌酐清除率和血清电解质水平能够调节肾功能。

科学家发现,SCA患者中非裔美国人、糖尿病患者、慢性阻塞性肺病患者和慢性肾病患者的比例远远高于对照组。SCA患者血液透析的几率也高于对照组。此外,给SCA患者开的利尿剂也比β阻滞剂利用率相同的对照者多,尤其是髓袢利尿剂。血钙水平低于8.95毫克/分升与SCA几率比水平高于9.55毫克/分升时升高1.3倍有关(风险比2.33)。

该研究的论文发表于2017年9月21日的《梅奥临床学报》(Mayo Clinic Proceedings)杂志。领衔作者、西达斯-西奈心脏研究所博士后Hirad Yarmohammadi大夫说:“我们的研究显示,如果血清钙水平较低,即使在正常范围内,也会增加突发性心脏骤停的风险。虽然我们的成果这时还不能用于临床,但已向目标——通过更好地预测风险来改进病人护理——迈出了一大步。”

Related Links:
西达斯-西奈心脏研究所

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more